undamentalytics Newsletter

Soderberg Shawn Marie: insider trades

Officer at 2 companies we cover. No open-market purchases and 24 sales not made under a pre-set plan, reported from March 9, 2015 to August 18, 2026.

What happened after Soderberg Shawn Marie’s sales?

After their sales, the shares moved +91.9% against the index over 12 months on average (a negative figure means selling was the right call); 53% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Soderberg Shawn Marie: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 23 +24.2% +1.9% 48% 8 0.94 0.38 No reliable evidence
Sales, 12 months after the report 19 +91.9% −14.7% 53% 7 0.67 0.53 No reliable evidence
Sales, 12 months after the trade 19 +96.0% −12.8% 53% 7 0.68 0.52 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Bloom Energy BE See Remarks020October 14, 2020August 18, 2026
Bio-rad Laboratories, Inc. BIO EVP, General Counsel, Sec04March 9, 2015December 15, 2015

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
August 18, 2026August 14, 2026 BE Sale $676,272 not yetnot yetnot yet
June 17, 2026June 16, 2026 BE Sale $820,286 −21.5%not yetnot yet
February 19, 2026February 17, 2026 BE Sale $465,014 +100.6%not yetnot yet
November 18, 2025November 14, 2025 BE Sale $463,625 +43.9%not yetnot yet
November 7, 2025November 5, 2025 BE Sale $5,169,906 +9.9%not yetnot yet
August 29, 2025August 28, 2025 BE Sale $1,300,000 +86.1%+302.3%+256.9%
August 20, 2025August 18, 2025 BE Sale $67,903 +138.4%+333.6%+323.5%
August 15, 2025August 13, 2025 BE Sale $2,074,969 +135.9%+323.5%+399.9%
May 14, 2025May 14, 2025 BE Sale $54,822 +119.2%+1178.8%+1235.5%
May 17, 2024May 16, 2024 BE Sale $14,117 −16.7%+30.8%+42.7%
April 18, 2023April 17, 2023 BE Sale $173,312 −15.2%−69.0%−70.1%
February 23, 2023February 22, 2023 BE Sale $335,713 −41.5%−86.1%−91.1%
December 19, 2022December 16, 2022 BE Sale $71,588 −14.7%−54.3%−60.8%
November 17, 2022November 16, 2022 BE Sale $59,681 +5.4%−55.4%−56.6%
May 20, 2022May 19, 2022 BE Sale $37,681 +45.6%−19.5%−14.4%
April 19, 2022April 18, 2022 BE Sale $167,223 −11.6%−14.8%−12.9%
March 17, 2022March 16, 2022 BE Sale $97,224 −11.7%−14.7%−14.6%
February 18, 2021February 16, 2021 BE Sale $261,832 −38.4%−54.5%−63.9%
January 28, 2021January 26, 2021 BE Sale $95,641 −38.7%−82.1%−78.0%
October 14, 2020October 13, 2020 BE Sale $326,527 +82.6%−19.4%−21.8%
December 15, 2015December 14, 2015 BIO Sale $257,450 −3.1%+20.7%+20.0%
December 4, 2015December 3, 2015 BIO Sale $11,628 +1.9%+21.0%+20.8%
September 14, 2015September 11, 2015 BIO Sale $20,900 −6.8%+2.4%+1.8%
March 9, 2015March 5, 2015 BIO Sale $14,285 +7.4%+2.1%+6.2%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Soderberg Shawn Marie traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.